Immunopotentiator
US10556004B2 · kind B2 · utility
0Cited by
4References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 9, 2014 |
| Grant date | Feb 11, 2020 |
| Priority date | — |
| Expiry date | Feb 23, 2035 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/55583
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
There is provided an immunopotentiator comprising, as an active ingredient, a modified β-glucan which β-glucan and poly(hydroxy acid) are covalently bonded. The immunopotentiator can potently enhance the immunopotentiating effect of β-glucan.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.